Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 9,534 $ 8,210
INVESTING ACTIVITIES    
Purchase of medical equipment, property and equipment (16,420) (4,521)
Proceeds from sale of medical equipment, property and equipment 2,239 2,344
NET CASH USED IN INVESTING ACTIVITIES (14,181) (2,177)
FINANCING ACTIVITIES    
Principal payments on term loans, capital lease obligations and other financing (3,915) (5,048)
Cash proceeds from term loans, equipment line and other financing 7,462 9,660
Debt issuance costs (3) (27)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (295) (5)
Common stock repurchased as part of Repurchase Program (10,291)
Cash proceeds from stock plans 237 91
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 3,486 (5,620)
Net change in cash and cash equivalents (1,161) 413
Cash and cash equivalents, beginning of period 4,318 3,469
Cash and cash equivalents, end of period $ 3,157 $ 3,882